CORMORANT ASSET MANAGEMENT, LP – Eledon Pharmaceuticals, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$3.37M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+13.11%
quarter
Eledon Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -6.25% | -81.59K shares | 193K | $2.76 | 1.22M |
Q2 2022 | share | 0.00% | 0 shares | -1.95M | $2.44 | 1.30M | |
Q1 2022 | share | 0.00% | 0 shares | -613K | $3.94 | 1.30M | |
Q4 2021 | share | 0.00% | 0 shares | -2.31M | $4.36 | 1.30M | |
Q3 2021 | share | Decrease | -7.80% | -110.40K shares | -3.13M | $6.18 | 1.30M |
Q2 2021 | share | 0.00% | 0 shares | -3.94M | $7.91 | 1.41M | |
Q1 2021 | share | Increase | 0.00% | 1.41M shares | 15.14M | $10.7 | 1.41M |